Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Korro Bio
KRRO
$192M
| $1.09M | ﹤0.01% |
2,189
+171
| +8% | +$83.5K |
|
3327
Lineage Cell Therapeutics
LCTX
$268M
| $1.09M | ﹤0.01% |
381,215
+308,316
| +423% | +$798K |
|
3328
Red River Bancshares
RRBI
$685M
| $1.08M | ﹤0.01% |
21,476
-1,650
| -7% | -$89.6K |
|
|
MILE
3329
DELISTED
Metromile, Inc. Common Stock
MILE
| $1.08M | ﹤0.01% |
118,147
+91,289
| +340% | +$817K |
|
|
DOYU
3330
DouYu International Holdings
DOYU
$140M
| $1.07M | ﹤0.01% |
15,721
-4,140
| -21% | -$356K |
|
3331
Cartesian Therapeutics
RNAC
$257M
| $1.07M | ﹤0.01% |
8,578
+2,018
| +31% | +$240K |
|
3332
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $1.07M | ﹤0.01% |
10,252
+320
| +3% | +$32.8K |
|
3333
Mid Penn Bancorp
MPB
$979M
| $1.07M | ﹤0.01% |
39,084
+3,202
| +9% | +$87.1K |
|
3334
Mitsubishi UFJ Financial
MUFG
$262B
| $1.07M | ﹤0.01% |
197,795
+15,318
| +8% | +$85.2K |
|
|
ADVM
3335
DELISTED
Adverum Biotechnologies
ADVM
| $1.07M | ﹤0.01% |
30,603
-1,649
| -5% | -$88.8K |
|
3336
Tonix Pharmaceuticals
TNXP
$209M
| $1.07M | ﹤0.01% |
+2
| New | +$1.47M |
|
3337
iShares MSCI Poland ETF
EPOL
$823M
| $1.07M | ﹤0.01% |
49,801
-3,693
| -7% | -$77.1K |
|
|
CD
3338
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $1.07M | ﹤0.01% |
+70,856
| New | +$1.06M |
|
3339
LCNB Corp
LCNB
$283M
| $1.07M | ﹤0.01% |
65,174
-34,355
| -35% | -$603K |
|
|
ARD
3340
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $1.06M | ﹤0.01% |
43,439
-569
| -1% | -$14.7K |
|
3341
Neurogene
NGNE
$701M
| $1.06M | ﹤0.01% |
5,757
-30
| -0.5% | -$6.64K |
|
3342
The Honest Company
HNST
$526M
| $1.06M | ﹤0.01% |
+65,565
| New | +$1.1M |
|
3343
Cadiz
CDZI
$283M
| $1.06M | ﹤0.01% |
77,973
-7,816
| -9% | -$93.6K |
|
3344
Spruce Power Holding Corp
SPRU
$35.8M
| $1.06M | ﹤0.01% |
15,914
+11,438
| +256% | +$674K |
|
3345
BGSF Inc
BGSF
$59.2M
| $1.06M | ﹤0.01% |
85,852
-25,387
| -23% | -$330K |
|
|
GORV
3346
DELISTED
Lazydays
GORV
| $1.06M | ﹤0.01% |
1,604
+518
| +48% | +$353K |
|
3347
iShares MSCI Europe Small-Cap ETF
IEUS
$186M
| $1.06M | ﹤0.01% |
+15,244
| New | +$1.07M |
|
3348
Ceco Environmental
CECO
$4.57B
| $1.06M | ﹤0.01% |
147,440
-6,841
| -4% | -$52.9K |
|
3349
South Plains Financial
SPFI
$861M
| $1.06M | ﹤0.01% |
45,647
-625
| -1% | -$14.3K |
|
3350
NN Inc
NNBR
$305M
| $1.05M | ﹤0.01% |
143,161
-28
| -0% | -$210 |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.